DaBomb Protein Corp., a specialized biotech company, primarily engages in the development of antibiotics alternatives in animal health industry. It offers plant protein, including DaBomb-P (Aqua) and DaBomb-P (Livestock); antibiotics alternatives, such as DBT-100 HT and DBT-100 LS; and pet care products comprising LACTOTIDES HEALTH A+ and Liqui-TIDE bandages. The company was founded in 2001 and is based in Tainan City, Taiwan.
Stock data | 2024 | Change |
---|---|---|
Price | $0.69567990595033 | N/A |
Market Cap | $41.54M | N/A |
Shares Outstanding | 59.71M | N/A |
Employees | 0 | N/A |